We are upgrading the repository! A content freeze is in effect until December 11, 2024. New submissions or changes to existing items will not be allowed during this period. All content already published will remain publicly available for searching and downloading. Updates will be posted in the Website Upgrade 2024 FAQ in the sidebar Help menu. Reach out to escholarship@umassmed.edu with any questions.
Antiviral autophagy restrictsRift Valley fever virus infection and is conserved from flies to mammals
| dc.contributor.author | Moy, Ryan H. | |
| dc.contributor.author | Gold, Beth | |
| dc.contributor.author | Molleston, Jerome M. | |
| dc.contributor.author | Schad, Veronica | |
| dc.contributor.author | Yanger, Kilangsungla | |
| dc.contributor.author | Salzano, Mary-Virginia | |
| dc.contributor.author | Yagi, Yoshimasa | |
| dc.contributor.author | Fitzgerald, Katherine A | |
| dc.contributor.author | Stanger, Ben Z. | |
| dc.contributor.author | Soldan, Samantha S. | |
| dc.contributor.author | Cherry, Sara | |
| dc.date | 2022-08-11T08:09:08.000 | |
| dc.date.accessioned | 2022-08-23T16:19:06Z | |
| dc.date.available | 2022-08-23T16:19:06Z | |
| dc.date.issued | 2014-01-16 | |
| dc.date.submitted | 2014-11-26 | |
| dc.identifier.citation | Immunity. 2014 Jan 16;40(1):51-65. doi: 10.1016/j.immuni.2013.10.020. Epub 2013 Dec 26. <a href="http://dx.doi.org/10.1016/j.immuni.2013.10.020">Link to article on publisher's site</a> | |
| dc.identifier.issn | 1074-7613 (Linking) | |
| dc.identifier.doi | 10.1016/j.immuni.2013.10.020 | |
| dc.identifier.pmid | 24374193 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.14038/34965 | |
| dc.description.abstract | Autophagy has been implicated as a component of host defense, but the significance of antimicrobial autophagy in vivo and the mechanism by which it is regulated during infection are poorly defined. Here we found that antiviral autophagy was conserved in flies and mammals during infection with Rift Valley fever virus (RVFV), a mosquito-borne virus that causes disease in humans and livestock. In Drosophila, Toll-7 limited RVFV replication and mortality through activation of autophagy. RVFV infection also elicited autophagy in mouse and human cells, and viral replication was increased in the absence of autophagy genes. The mammalian Toll-like receptor adaptor, MyD88, was required for anti-RVFV autophagy, revealing an evolutionarily conserved requirement for pattern-recognition receptors in antiviral autophagy. Pharmacologic activation of autophagy inhibited RVFV infection in mammalian cells, including primary hepatocytes and neurons. Thus, autophagy modulation might be an effective strategy for treating RVFV infection, which lacks approved vaccines and therapeutics. | |
| dc.language.iso | en_US | |
| dc.relation | <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=24374193&dopt=Abstract">Link to Article in PubMed</a> | |
| dc.relation.url | http://dx.doi.org/10.1016/j.immuni.2013.10.020 | |
| dc.subject | Allyl Compounds | |
| dc.subject | Animals | |
| dc.subject | Antiviral Agents | |
| dc.subject | Autophagy | |
| dc.subject | Cells, Cultured | |
| dc.subject | Drosophila | |
| dc.subject | Evolution, Molecular | |
| dc.subject | Hepatocytes | |
| dc.subject | Humans | |
| dc.subject | Infection Control | |
| dc.subject | Mammals | |
| dc.subject | Mice | |
| dc.subject | Myeloid Differentiation Factor 88 | |
| dc.subject | Neurons | |
| dc.subject | Quinazolines | |
| dc.subject | Rats | |
| dc.subject | Rift Valley Fever | |
| dc.subject | Rift Valley fever virus | |
| dc.subject | Toll-Like Receptor 7 | |
| dc.subject | Virus Replication | |
| dc.subject | Cells | |
| dc.subject | Immunity | |
| dc.subject | Immunology and Infectious Disease | |
| dc.subject | Immunology of Infectious Disease | |
| dc.subject | Infectious Disease | |
| dc.subject | Parasitic Diseases | |
| dc.subject | Virus Diseases | |
| dc.subject | Viruses | |
| dc.title | Antiviral autophagy restrictsRift Valley fever virus infection and is conserved from flies to mammals | |
| dc.type | Journal Article | |
| dc.source.journaltitle | Immunity | |
| dc.source.volume | 40 | |
| dc.source.issue | 1 | |
| dc.identifier.legacycoverpage | https://escholarship.umassmed.edu/infdis_pp/186 | |
| dc.identifier.contextkey | 6399383 | |
| html.description.abstract | <p>Autophagy has been implicated as a component of host defense, but the significance of antimicrobial autophagy in vivo and the mechanism by which it is regulated during infection are poorly defined. Here we found that antiviral autophagy was conserved in flies and mammals during infection with Rift Valley fever virus (RVFV), a mosquito-borne virus that causes disease in humans and livestock. In Drosophila, Toll-7 limited RVFV replication and mortality through activation of autophagy. RVFV infection also elicited autophagy in mouse and human cells, and viral replication was increased in the absence of autophagy genes. The mammalian Toll-like receptor adaptor, MyD88, was required for anti-RVFV autophagy, revealing an evolutionarily conserved requirement for pattern-recognition receptors in antiviral autophagy. Pharmacologic activation of autophagy inhibited RVFV infection in mammalian cells, including primary hepatocytes and neurons. Thus, autophagy modulation might be an effective strategy for treating RVFV infection, which lacks approved vaccines and therapeutics.</p> | |
| dc.identifier.submissionpath | infdis_pp/186 | |
| dc.contributor.department | Department of Medicine, Division of Infectious Diseases and Immunology | |
| dc.source.pages | 51-65 |
Files in this item
Name:
Publisher version
This item appears in the following Collection(s)
Related items
Showing items related by title, author, creator and subject.
-
Suppressive Oligodeoxynucleotides Inhibit Cytosolic DNA Sensing Pathways: A DissertationThe innate immune system provides an essential first line of defense against infection. Innate immune cells detect pathogens through several classes of Pattern Recognition Receptors (PRR) allowing rapid response to a broad spectrum of infectious agents. Activated receptors initiate signaling cascades that lead to the production of cytokines, chemokines and type I interferons all of which are vital for controlling pathogen load and coordinating the adaptive immune response. Detection of nucleic acids by the innate immune system has emerged as a mechanism by which infection is recognized. Recognition of DNA is complex, influenced by sequence, structure, covalent modification and subcellular localization. Interestingly certain synthetic oligodeoxynucleotides comprised of the TTAGGG motif inhibit proinflammatory responses in a variety of disease models. These suppressive oligodeoxynucleotides (sup ODN) have been shown to directly block TLR9 signaling as well as prevent STAT1 and STAT4 phosphorylation. Recently AIM2 has been shown to engage ASC and assemble an inflammasome complex leading to the caspase-1-dependent maturation of IL-1β and IL-18. The AIM2 inflammasome is activated in response to cytosolic dsDNA and plays an important role in controlling replication of murine cytomegalovirus (MCMV). In the second chapter of this thesis, a novel role for the sup ODN A151 in inhibiting cytosolic nucleic acid sensing pathways is described. Treatment of dendritic cells and macrophages with the A151 abrogated type I IFN, TNF-α and ISG induction in response to cytosolic dsDNA. A151 also reduced INF-β and TNF-α induction in BMDC and BMDM responding to the herpesviruses HSV-1 and MCMV but had no effect on the responses to LPS or Sendai virus. In addition, A151 abrogated caspase-1-dependent IL-1β and IL-18 maturation in dendritic cells stimulated with dsDNA and MCMV. Although inhibition of interferon-inducing pathways and inflammasome assembly was dependent on backbone composition, sequence differentially affected these pathways. While A151 more potently suppressed the AIM2 inflammasome, a related construct C151, proved to be a more potent inhibitor of interferon induction. A151 suppressed inflammasome signaling by binding to AIM2 and competing with immune-stimulatory DNA. The interaction of A151 and AIM2 prevented recruitment of the adapter ASC and assembly of the macromolecular inflammasome complex. Collectively, these findings reveal a new route by which suppressive ODNs modulate the immune system and unveil novel applications for suppressive ODNs in the treatment of infectious and autoimmune diseases. The innate immune response to HSV-1 infection is critical for controlling early viral replication and coordinating the adaptive immune response. The cytokines IL-1β and IL-18 are important effector molecules in the innate response to HSV-1 in vivo. However, the PRRs responsible for the production and maturation of these cytokines have not been fully defined. In the third chapter of this thesis, The TLR2-MyD88 pathway is shown to be essential for the induction of pro-IL-1β transcription in dendritic cells and macrophages responding to HSV-1. The HSV-1 immediate-early protein ICP0 has previously been shown to block TLR2 responses and in keeping with this finding, ICP0 blocked pro-IL-1β expression. Following translation, pro-IL-1β exists as an inactive precursor that must be proteolytically cleaved by a multiprotein complex known as the inflammasome to yield its active form. Inflammasomes are composed of cytoplasmic receptors such as NLRP3 or AIM2, the adapter molecule ASC, and pro-caspase-1. In the present study we found that the NLRP3 inflammasome is important for maturation of IL-1β in macrophages and dendritic cells responding to HSV-1. In contrast the related NLRP12 protein controls IL-1β production in neutrophils. These data indicate that sensing of HSV-1 by TLR2 drives pro-IL-1β transcription and infection activates the inflammasome to mature this cytokine. Moreover, these studies reveal cell type-specific roles for NLRP3 and NLRP12 in inflammasome assembly.
-
Multipronged CD4(+) T-cell effector and memory responses cooperate to provide potent immunity against respiratory virusOver the last decade, the known spectrum of CD4(+) T-cell effector subsets has become much broader, and it has become clear that there are multiple dimensions by which subsets with a particular cytokine commitment can be further defined, including their stage of differentiation, their location, and, most importantly, their ability to carry out discrete functions. Here, we focus on our studies that highlight the synergy among discrete subsets, especially those defined by helper and cytotoxic function, in mediating viral protection, and on distinctions between CD4(+) T-cell effectors located in spleen, draining lymph node, and in tissue sites of infection. What emerges is a surprising multiplicity of CD4(+) T-cell functions that indicate a large arsenal of mechanisms by which CD4(+) T cells act to combat viruses.
-
A single vertebrate DNA virus protein disarms invertebrate immunity to RNA virus infectionVirus-host interactions drive a remarkable diversity of immune responses and countermeasures. We found that two RNA viruses with broad host ranges, vesicular stomatitis virus (VSV) and Sindbis virus (SINV), are completely restricted in their replication after entry into Lepidopteran cells. This restriction is overcome when cells are co-infected with vaccinia virus (VACV), a vertebrate DNA virus. Using RNAi screening, we show that Lepidopteran RNAi, Nuclear Factor-kappaB, and ubiquitin-proteasome pathways restrict RNA virus infection. Surprisingly, a highly conserved, uncharacterized VACV protein, A51R, can partially overcome this virus restriction. We show that A51R is also critical for VACV replication in vertebrate cells and for pathogenesis in mice. Interestingly, A51R colocalizes with, and stabilizes, host microtubules and also associates with ubiquitin. We show that A51R promotes viral protein stability, possibly by preventing ubiquitin-dependent targeting of viral proteins for destruction. Importantly, our studies reveal exciting new opportunities to study virus-host interactions in experimentally-tractable Lepidopteran systems.
